Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: The impact of the addition of rituximab to CHOP chemotherapy

被引：0
|
作者：
Villa, D.
Savage, K. J.
Sehn, L. H.
Connors, J.
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
[2] British Columbia Canc Agcy, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8037
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
    Villa, D.
    Connors, J. M.
    Shenkier, T. N.
    Gascoyne, R. D.
    Sehn, L. H.
    Savage, K. J.
    ANNALS OF ONCOLOGY, 2010, 21 (05) : 1046 - 1052
  • [2] THE IMPACT OF ADDITION OF RITUXIMAB TO CHEMOTHERAPY ON INCIDENCE OF CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Law, M.
    Yip, S.
    Chan, H.
    Lai, H.
    Ha, C.
    ANNALS OF ONCOLOGY, 2011, 22 : 226 - 226
  • [3] Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis
    Zhang, Jing
    Chen, Bobin
    Xu, Xiaoping
    LEUKEMIA & LYMPHOMA, 2014, 55 (03) : 509 - 514
  • [4] Effects of addition of rituximab to chemotherapy on central nervous system events in patients with diffuse large B-cell lymphoma
    Law, Man Fai
    Chan, Hay Nun
    Lai, Ho Kei
    Ha, Chung Yin
    Ng, Celia
    Yeung, Yiu Ming
    Yip, Sze Fai
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 747 - 752
  • [5] Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era
    Vassilakopoulos, Theodoros P.
    Panitsas, Fotios
    Mellios, Zois
    Apostolidis, John
    Piperidou, Alexia
    Michael, Michalis D.
    Gurion, Ronit
    Akay, Meltem
    Hatzimichael, Eleftheria
    Karakatsanis, Stamatis J.
    Dimou, Maria
    Kalpadakis, Christina
    Katodritou, Eirini
    Leonidopoulou, Theoni
    Kotsianidis, Ioannis
    Giatra, Chara
    Kanellias, Nikolaos
    Sayyed, Ayman
    Tadmor, Tamar
    Kaynar, Leylagul
    Zektser, Miri
    Symeonidis, Argiris
    Atalar, Sc
    Verrou, Evgenia
    Gutwein, Odit
    Ganzel, Chezi
    Karianakis, Giorgos
    Isenberg, Jonathan
    Gainaru, Gabriela
    Triantafyllou, Theodora
    Vrakidou, Efimia
    Palassopoulou, Maria
    Ozgur, Mehmet
    Paydas, Semra
    Tsirigotis, Panagiotis
    Tsirogianni, Maria
    Tuglular, Tulin
    Chatzidimitriou, Chrysovalantou
    Kotsopoulou, Maria
    Terpos, Evangelos
    Zikos, Panagiotis
    Koumarianou, Argyro
    Poziopoulos, Christos
    Boutsis, Dimitrios
    Gafter-Gvili, Anat
    Karmiris, Themistoklis
    Angelopoulou, Maria K.
    Papaioannou, Maria Bakiri
    Pangalis, Gerassimos
    Panayiotidis, Panayiotis
    BLOOD, 2022, 140 : 9554 - 9556
  • [6] Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era
    Vassilakopoulos, Theodoros P.
    Panitsas, Fotios
    Mellios, Zois
    Apostolidis, John
    Michael, Michalis
    Gurion, Ronit
    Ferhanoglu, Burhan
    Hatzimichael, Eleftheria
    Karakatsanis, Stamatios
    Dimou, Maria
    Kalpadakis, Christina
    Katodritou, Eirini
    Leonidopoulou, Theoni
    Kotsianidis, Ioannis
    Giatra, Hara
    Kanellias, Nick
    Sayyed, Ayman
    Tadmor, Tamar
    Akay, Olga Meltem
    Angelopoulou, Maria K.
    Horowitz, Netanel
    Bakiri, Maria
    Pangalis, Gerassimos A.
    Panayiotidis, Panayiotis
    Papageorgiou, Sotirios G.
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (01) : 97 - 107
  • [7] Central nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors
    Uni, Masahiro
    Kagoya, Yuki
    Nannya, Yasuhito
    Nakamura, Fumihiko
    Kurokawa, Mineo
    LEUKEMIA & LYMPHOMA, 2015, 56 (06) : 1869 - 1871
  • [8] Central Nervous System Relapse in Patients with Diffuse Large B-Cell Lymphoma: Analysis of Incidence and Prognostic Factors
    Uni, Masahiro
    Kagoya, Yuki
    Nannya, Yasuhito
    Nakamura, Fumihiko
    Kurokawa, Mineo
    BLOOD, 2014, 124 (21)
  • [9] The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma
    Mitrovic, Zdravko
    Bast, Martin
    Bierman, Philip J.
    Bociek, Robert G.
    Vose, Julie M.
    Chan, Wing C.
    Armitage, James O.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (03) : 401 - 403
  • [10] Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression model
    Chihara, Dai
    Oki, Yasuhiro
    Matsuo, Keitaro
    Onoda, Hiroshi
    Taji, Hirofumi
    Yamamoto, Kazuhito
    Morishima, Yasuo
    LEUKEMIA & LYMPHOMA, 2011, 52 (12) : 2270 - 2275
12345